Pharmacy professionals may wish to review the Ministry of Health and Long-Term Care's Ontario Public Drug Program resources, where you’ll find a Notice from the Executive Officer: Funding of Mifegymiso, a FAQ for health care providers, and a FAQ for patients (all published on August 3, 2017).